HITCO Holding History

Mr. Jamshid Babaie commenced his professional & commercial activities in 1965 by collaborating with Tolid Darou (One of the prominent pharmaceutical producer at a time).

Tolid Darou used to be managed by the Khosroshahi gentlemen (as a family privately owned company) in that year.

This fruitful cooperation and latter partnership, was fulfilled with practical treasured experiences captured by Mr. Jamshid Babaie from the well-reputed entrepreneur, Mr. Khosroshahi.

Mr. Jamshid Babaie, in line with reaching to his thriving goals, after a period of 4 successful years in Tolid Darou and leaving behind a cherished touch, joined the Don Baxter international firm (Today is known as the “Iranian Intravenous Injectable Solutions”).

Given the rich experience and the knowledge of Mr. Babaie in manufacturing and distributing of injection serums, he launched a dialogue with HOECHST AG. He managed to persuade the giant corporate to enter in Iran market, and given that a developed and equipped production site was already in place, the German side agreed to even transfer the know-how. The German company found the facilities impressive and was encouraged to  invest. 

Between the years 1970 to late 1980, HOECHST AG became the market leader, supporting millions of Iranian patients, as a result of remarkable efforts and expertise of Mr. Babaie. Regretfully, the chapter of HOECHST AG was closed in the country, as a result of the devastating battle, imposed by Iraq which took close to 8 years.

In 1981, Jamshid Babaie recommenced his business affairs, as a dynamic member of the Iranian healthcare society, by founding two healthcare oriented firms, Aradco and Shiraz Health. These affairs enriched HITCO Holding  history. These two firms acted as the exclusive representative of German Lawton products, as well as supplying surgical sutures, tools, and a wide range of disposables. 

This setup sustained till 1997, after which, in line with policies of supporting local production in the country, Mr. Jamshid Babaie eagerly chased his career in Varian Teb Company. Varian Teb  used to provide quality monofilament and multifilament surgical sutures.

Varian Teb continued to expand till 2001 by the leadership of Jamshid Babaie and consequently merged with Teb Novin Group of companies that used to actively work with universities, seeking innovative solutions.

In 2005, Mr. Jamshid Babaie, after ensuring that adequate skills, knowledge, as well as a patient oriented mindset, all have been professed by his son, Ali Bababie, encouraged him to join the company.

It did not take a long time for Mr. Ali Babaie, to signify his impact. He managed to enhance the revenue considerably and turned into the best performer of the company, during the first year.

Accordingly, Mr. Jamshid Babaie, allocated the full responsibility of the organization to Ali Babaie, and since he has been pursuing the prosperous path of Jamshid Babaie, and while leading the company, in parallel, managed to become proficient at several areas such finance, marketing, business operation and negotiation techniques.

He successfully negotiated with mega firms such as 3M, Teleflex and HatMann and turned into the official scientific representative of a certain ranges of products. In terms of founding, he established distributors such as Teb Novin and Momtaz.

In 2010, Mr. Ali Babaie made the decision to continue his journey, individually. Hence, left the Iran Pharmis Group, and established a new corporate call Health Investment Company (HITCO Group), which today represents well known brands, such as G.U.M, Pelz Grpup of Germany and multiple pharmaceutical premium international companies.

The HITCO Group, by an agile and to some extent intensive expansion plans, seems to be family with 28 subsidiaries.

Read More About Hitco Group
Imen Pharmed Iranian
Established in 2011, within three years Imen Pharmed Iranian Vaccine Company produced the BCG vaccine as the first dynamic knowledge-based private vaccine company in cooperation with the Pasteur Institute, and launched the product on the market.
2011
Pak Salamat Tamin
Established in 2011, within three years Imen Pharmed Iranian Vaccine Company produced the BCG vaccine as the first dynamic knowledge-based private vaccine company in cooperation with the Pasteur Institute, and launched the product on the market.
2013
Tamin Pharmed Tehran
In 2017, Tamin Pharmed Tehran Company was established with the aim of producing licensed products, importing emergency medicine and producing various herbal medicines. This company also is producing various products such as Swiss Energy Sustained Release Capsules.
2017
Tamin Shafa Pars
In 2017, Tamin Shafa Pars Company was established with the aim of importing and producing disposable medical items, as well as importing specialized products, especially for dialysis and diabetic patients. This company has EUROSAFE and CANSafe brand, whose producys are produced under contract. In line with its specialized activities, this company has set its agenda to work on all types of colostomy bags, new wound treatment dressings, and all types of items related to diabetic patients, dialysis products for patients, and other products related to this category of diseases.
2018
Health Investment Tamin
In 2020, Health Investment Tamin Company was established with the aim of establishing Healt Holding, and the shares of all companies were transferred to this company.
2019
Tamgene Salamat Pars
In 2020, Tamgen Salamat Pars Company was founded and started operating as a knowledge-based company with the aim of developing biotechnological drugs from the cell stage and working on some sensitive antibody molecules and internal growth hormone from the cell line stage.
2019
Exon Salamat Tamin
In 2020, Exon Salamat Tamim compay was established with the aim of becoming one of the leading companies in the health distribution industry of the country and as one of the subsidiary companies of Hitco group.
2019
Kiara Zist Phamed
In 2023, Kiara Zist Pharmed Company was established with the aim of producing quality skin and hair care products with the origin of bioactive ingredients in the form of a knowledge-based company.
2019
Delsa Darou Pars
In 2020, Delsa Darou Company was established with the aim of distributing all kinds of medicines, pharmaceutical supplements, sports supplements, cosmetic products, health products and disposable medical items.
2019
Aradco Pars
In 2021, Aradco Pars Company was established with the aim of producing biological medicine under license of prominent companies and became one of Hitco holding’s subsidiary companies.
2020
Pishtaz Darou Tamin
In 2022, Darou Behbood Tomin Company was founded and started its activity as one of the subsidiary companies of Hitco Holding with the aim of creating production-oriented technical knowledge in the field of drug delivery systems.
2021
Darou Behbood Tamin
In 2022, Darou Behbood Tomin Company was founded and started its activity as one of the subsidiary companies of Hitco Holding with the aim of creating production-oriented technical knowledge in the field of drug delivery systems.
2021
Shetab Dahandeh Dana
In 2022, the Dana Accelerator aimed to produce biological drugs needed by the country's rare patients, develop diagnostic and screening methods for the country's rare diseases, and produce non-biological medicines and other items needed by the country's rare patients, It is under financial support and investment of Health Invesment Tamin Company (Hitco).
2021
Farzanegan Kish
In 2023, Farzangan Kish Company was placed as one of the subsidiaries of Hitco Holding, which started its activity in the field of producing medical equipment from 2003.
2022
Sorinet
In 2023, the Hitco group purchased the company's share of Sorinet Company to produce all kinds of health and cosmetic products under license.
2022
Novin Darou Zist Fanavar Haraz
In 2023, Hitco purchased part of the shares of knowledge-based Novin Darou Zist Fanavar Haraz Company in order to manufacture medicines derived from blood plasma for the treatment of patients.
2022
Zhoubin Mehr
In 2023, Tamin Capital Salamat Company purchased the shares and production factories of Zhoubin Mehr Food Industry Company with the aim of producing health-oriented dietary and organic food products with the CANFOOD brand.
2021
Cara Yakhteh Tajhiz Azma
In 2023, the Hitco Group purchased part of the shares of Kara Yakhte Tajhiz Azma Company. The Hitco Group continued its activities to treat cancer in Iran and the region by using a research group in the field of "construction and determination of characteristics of engineered lymphocytes, with a chimeric receptor containing a special nanobody for use in cancer immunocell therapy" and producing Children's leukemia vaccine.
2022
عکس رئیس هیئت مدیره هلدینگ هیتکو

A Message from the Chairman and Owner

We, represented as the Hitco group, proudly apply our ideas, knowledge, and experience to qualify all our work and professional efforts, aimed to improve the well-being and health of the society. We proudly consider using the highest professional and ethical standards in every affair we conduct. We have considerable respect for the rights of our colleagues, customers, the society we are working in, the planet we live on, alongside the impacts of the actions that we undertake. This consideration is in accordance with the fundamental values and corporate goals. Working intelligently with companionship and empathy towards the goals of our organization and the prosperity of the country, it is hoped to provide knowledge and expertise fast, precisely, and excellently.

Chairman and Owner
Ali Babaie

Our Mission

To propel toward the ambitious vision, the scope of activities of the HITCO Group, has not been confined to the supply of therapeutic & preventive agents, meaning that the education of the healthcare community, patient centricity, as well as expediting treatment and diagnostic solutions, has always been equally cherished.

Our Vision

The perception is to improve the quality of life of the individuals, to the greatest spectrum possible, in national and international levels.

Philosophy

Our belief is that even solicitousness around the welfare of the humankind, is sacred

Values

CSR

Corporate Social Responsibility is a management concept whereby companies integrate social and environmental concerns into their business operations and interactions with their stakeholders. Some examples of CSR components are reducing carbon footprint and energy consumption, engaging in wildlife conservation initiatives, encouraging charity and volunteer work, supporting local communities, improving labor policies The core value of HITCO (Under the previous title of  Mehr Gostare Tamin Daroo) is to embed Corporate Social Responsibility (CSR) within all business affairs and to observe the social and environmental impact of each decision. “We believe actions speak louder “, thus, the corporation joined the UN Global Compact Supporters in 2011.

01

Patient Centricity

In line with the respected values and policies of the HITCO Group, the majority of the operational activities, are being carried out with the ultimate objective of serving the patients, as well as the public, not only in terms of product supply but also embedding various effective and consistent educative and awareness campaigns, throughout the year. Additionally, a thoughtfully designed weblog has been developed for the public in this context, within the corporate webpage, enriched with essential educative content. Meanwhile, the ambition is to create various web-based healthcare tools, tailored to each therapeutic area, assisting patients to adopt a healthier lifestyle, with an improved self-care mindset.

02

Enriching Local Production Capacity

HITCO Group believes in improving core production capacities of the country through two principal methodologies: - Supporting, empowering, and investing in the expansion of knowledge-based local start-ups, specializing in the development of modern healthcare solutions. Knowledge-based enterprises act as impactful facilitators, catalyzing the process of converting a knowledge or knowledge-based product, into a practical commodity in the market. - Encouraging world-class pharmaceutical & biotechnological pharma giants to transfer the know-how to the country, benefiting the overall healthcare community. Know-how is defined as a set of practical knowledge, skills, or expertise. In this context, it is referred to an assortment of methods or techniques of production of certain solutions in healthcare.

03

Diversity

Diversity has always been respected and considered in the human capital, in a way that employees with various backgrounds and ethnicities have become quite impactful and active members of the organization. Diversity has always been considered a respected attribute and well-thought-out in the agenda of the human capital & resource buildup, in a way that employees with various backgrounds, ethnicities & beliefs have turned into quite impactful and active members of the organization. Diversity in the workplace means having a workforce inclusive of different backgrounds and national origins. It means gender, socioeconomic, and cultural diversity — and beyond. It also means that the organization fosters a sense of belonging that makes everyone feel like they are part of the team.

04